Skip to Main Content

Paper Details

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies.
Nat Commun
8
2022
BRCA, BRCA-, BRCA-associated cancer, BRCA-associated cancers, BRCA-associated tumors, BRCA1, BRCA1/, BRCA1/2, BRCA1/2-mutant, BRCA1/2-mutant tumors, PARP, breast, ovarian, pancreas and prostate, cancer, germline, germline BRCA1/, homologous recombination deficiency, lung and esophagogastric adenocarcinomas, patients, platinum, tumor, tumors
Author NameAffiliation
Michael F BergerWeill Cornell Medical College
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerMemorial Sloan Kettering Cancer Center
Michael F BergerMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Chaitanya BandlamudiMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Chaitanya BandlamudiMemorial Sloan Kettering Cancer Center
Alexander DrilonMemorial Sloan Kettering Cancer Center
Alexander DrilonWeill Cornell Medical College
  • 1 - 8

Datasets

Release 1.2